Concepedia

Mari Hosonaga

MH

Statistics

Publications

10

Citations

328

H-Index

10

Active since

2011

Affiliations

Tokyo Medical University(Current)

The Cancer Institute Hospital

Japanese Foundation For Cancer Research

Keio University

Aichi Cancer Center

Mari Hosonaga is an author at Tokyo Medical University specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2011–2023

10

Publications

10

Induction of ZEB Proteins by Inactivation of RB Protein Is Key Determinant of Mesenchymal Phenotype of Breast Cancer

Yoshimi Arima, Hidemi Hayashi, Mikako Sasaki et al. · Journal of Biological Chemistry · 2012 · 70 citations · Full text

, , +13

Efficacy, safety, and biomarker analysis of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR-positive HER2-negative metastatic breast cancer: a phase II study (WJOG11418B NEWFLAME trial)

Jun Masuda, Hitomi Sakai, Junji Tsurutani et al. · Journal for ImmunoTherapy of Cancer · 2023 · 66 citations · Full text

, , +17

Expression of <scp>CD</scp>24 is associated with HER2 expression and supports HER2‐Akt signaling in HER2‐positive breast cancer cells

Mari Hosonaga, Yoshimi Arima, Eiji Sugihara et al. · Cancer Science · 2014 · 39 citations · Full text

, , +14

HER2 Heterogeneity Is Associated with Poor Survival in HER2-Positive Breast Cancer

Mari Hosonaga, Yoshimi Arima, Oltea Sampetrean et al. · International Journal of Molecular Sciences · 2018 · 36 citations · Full text

, , +14

RNA Sequencing Analysis Reveals Interactions between Breast Cancer or Melanoma Cells and the Tissue Microenvironment during Brain Metastasis

Ryo Sato, T. Nakano, Mari Hosonaga et al. · BioMed Research International · 2017 · 34 citations · Full text

, , +15

1–5 of 10